Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Polymorphism, Genetic  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Aleksic N, Juneja H, Folsom AR, et al. "Platelet Pl(A2) allele and incidence of coronary heart disease: results from the Atherosclerosis Risk In Communities (ARIC) Study." Circulation. 2000;102(16):1901-5.
Aleksic N, Folsom AR, Cushman M, Heckbert SR, Tsai MY, Wu KK. "Prospective study of the A455V polymorphism in the thrombomodulin gene, plasma thrombomodulin, and incidence of venous thromboembolism: the LITE Study." J Thromb Haemost. 2003;1(1):88-94.
de Andrade M, Thandi I, Brown S, Gotto A, Patsch W, Boerwinkle E. "Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis." Am J Hum Genet. 1995;56(6):1379-90.
F
Ferdinands JM, Mannino DM, Gwinn ML, Bray MS. "ADRB2 Arg16Gly polymorphism, lung function, and mortality: results from the Atherosclerosis Risk in Communities study." PLoS One. 2007;2(3):e289.
Folsom AR, Aleksic N, Ahn C, Boerwinkle E, Wu KK. "Beta-fibrinogen gene -455G/A polymorphism and coronary heart disease incidence: the Atherosclerosis Risk in Communities (ARIC) Study." Ann Epidemiol. 2001;11(3):166-70.
Folsom AR, Cushman M, Heckbert SR, Ohira T, Rasmussen-Torvik L, Tsai MY. "Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism." J Thromb Haemost. 2007;5(8):1674-8.
Folsom AR, Nieto FJ, McGovern PG, et al. "Prospective study of coronary heart disease incidence in relation to fasting total homocysteine, related genetic polymorphisms, and B vitamins: the Atherosclerosis Risk in Communities (ARIC) study." Circulation. 1998;98(3):204-10.
Folsom AR, Cushman M, Rasmussen-Torvik LJ, Heckbert SR, Tsai MY. "Prospective study of polymorphisms of the protein Z-dependent protease inhibitor and risk of venous thromboembolism." Thromb Haemost. 2007;97(3):493-4.
Fornage M, Lee CR, Doris PA, et al. "The soluble epoxide hydrolase gene harbors sequence variation associated with susceptibility to and protection from incident ischemic stroke." Hum Mol Genet. 2005;14(19):2829-37.
Franceschini N, Muallem H, Rose KM, Boerwinkle E, Maeda N. "Low density lipoprotein receptor polymorphisms and the risk of coronary heart disease: the Atherosclerosis Risk in Communities Study." J Thromb Haemost. 2009;7(3):496-8.
G
Gaubatz JW, Ghanem KI, Guevara J, Nava ML, Patsch W, Morrisett JD. "Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]." J Lipid Res. 1990;31(4):603-13.
Ghaddar HM, Folsom AR, Aleksic N, et al. "Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis." Circulation. 1998;98(25):2815-21.
Gordon AS, Tabor HK, Johnson AD, et al. "Quantifying rare, deleterious variation in 12 human cytochrome P450 drug-metabolism genes in a large-scale exome dataset." Hum Mol Genet. 2014;23(8):1957-63.
Grove ML, Morrison A, Folsom AR, Boerwinkle E, Hoelscher DM, Bray MS. "Gene-environment interaction and the GNB3 gene in the Atherosclerosis Risk in Communities study." Int J Obes (Lond). 2007;31(6):919-26.
O
Olshan AF, Li R, Pankow JS, et al. "Risk of atherosclerosis: interaction of smoking and glutathione S-transferase genes." Epidemiology. 2003;14(3):321-7.
R
Rasmussen-Torvik LJ, Cushman M, Tsai MY, et al. "The association of alpha-fibrinogen Thr312Ala polymorphism and venous thromboembolism in the LITE study." Thromb Res. 2007;121(1):1-7.
S
Selvaraj S, Seidelmann S, Silvestre OM, et al. "HFE H63D Polymorphism and the Risk for Systemic Hypertension, Myocardial Remodeling, and Adverse Cardiovascular Events in the ARIC Study." Hypertension. 2019;73(1):68-74.
Surguchov AP, Page GP, Smith L, Patsch W, Boerwinkle E. "Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia." Arterioscler Thromb Vasc Biol. 1996;16(8):941-7.
Surguchov AP, Boerwinkle E, Sharrett AR, Patsch W. "Effect of apolipoprotein E polymorphism on fasting retinyl palmitate level." Biochem Mol Med. 1995;55(2):156-7.
V
Volcik KA, Ballantyne CM, Braun MC, Coresh J, Mosley TH, Boerwinkle E. "Association of the complement factor H Y402H polymorphism with cardiovascular disease is dependent upon hypertension status: The ARIC study." Am J Hypertens. 2008;21(5):533-8.
Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Boerwinkle E. "Specific P-selectin and P-selectin glycoprotein ligand-1 genotypes/haplotypes are associated with risk of incident CHD and ischemic stroke: the Atherosclerosis Risk in Communities (ARIC) study." Atherosclerosis. 2007;195(1):e76-82.
Volcik KA, Barkley R A, Hutchinson RG, et al. "Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants." Am J Epidemiol. 2006;164(4):342-8.
Volcik KA, Ballantyne CM, Hoogeveen R, Folsom AR, Boerwinkle E. "Intercellular adhesion molecule-1 G241R polymorphism predicts risk of incident ischemic stroke: Atherosclerosis Risk in Communities study." Stroke. 2010;41(5):1038-40.
Volcik KA, Ballantyne CM, Coresh J, Folsom AR, Wu KK, Boerwinkle E. "P-selectin Thr715Pro polymorphism predicts P-selectin levels but not risk of incident coronary heart disease or ischemic stroke in a cohort of 14595 participants: the Atherosclerosis Risk in Communities Study." Atherosclerosis. 2006;186(1):74-9.
Volcik KA, Catellier D, Folsom AR, Matijevic N, Wasserman B, Boerwinkle E. "SELP and SELPLG genetic variation is associated with cell surface measures of SELP and SELPLG: the Atherosclerosis Risk in Communities Carotid MRI Study." Clin Chem. 2009;55(6):1076-82.
W
West NA, Tingle JV, Simino J, Selvin E, Bressler J. "The PPARG Pro12Ala Polymorphism and 20-year Cognitive Decline: Race and Sex Heterogeneity." Alzheimer Dis Assoc Disord. 2018;32(2):131-136.
Wu KK, Aleksic N, Ahn C, Boerwinkle E, Folsom AR, Juneja H. "Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease." Circulation. 2001;103(10):1386-9.